IL-10-Dependent Amelioration of Chronic Inflammatory Disease by Microdose Subcutaneous Delivery of a Prototypic Immunoregulatory Small Molecule

One of the interventional strategies to reestablish the immune effector/regulatory balance, that is typically altered in chronic inflammatory diseases (CID), is the reinforcement of endogenous immunomodulatory pathways as the one triggered by interleukin (IL)-10. In a recent work, we demonstrated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabares-Guevara, Jorge H., Jaramillo, Julio C., Ospina-Quintero, Laura, Piedrahíta-Ochoa, Christian A., García-Valencia, Natalia, Bautista-Erazo, David E., Caro-Gómez, Erika, Covián, Camila, Retamal-Díaz, Angello, Duarte, Luisa F., González, Pablo A., Bueno, Susan M., Riedel, Claudia A., Kalergis, Alexis M., Ramírez-Pineda, José R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297659/
https://www.ncbi.nlm.nih.gov/pubmed/34305950
http://dx.doi.org/10.3389/fimmu.2021.708955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297659/
https://www.ncbi.nlm.nih.gov/pubmed/34305950
http://dx.doi.org/10.3389/fimmu.2021.708955

Ejemplares similares